Weisse et al: Procedural descriptions and survival times for hepatic arteriovenous malformations (HAVM) in animals receiving primarily conservative treatment, arterial embolization, or dominant outflow vein occlusion
Veterinary Surgery 3, 2026

Procedural descriptions and survival times for hepatic arteriovenous malformations (HAVM) in animals receiving primarily conservative treatment, arterial embolization, or dominant outflow vein occlusion

🔍 Key Findings

  • Surgical management significantly improves survival vs medical therapy, with MST ~1942d vs 567d (p = .028), supporting intervention over conservative care.
  • DOV occlusion achieves superior initial occlusion rates (95% vs 56% for TAE; p = .007), making it more reliable for immediate flow cessation.
  • TAE has significantly higher recurrence rates (53% vs 15% for DOV; p < .001), often requiring repeat procedures.
  • Residual HAVM flow is more common after TAE (44% vs 5%), reflecting difficulty targeting the nidus via arterial routes.
  • Overall survival time between TAE and DOV is not significantly different, but more DOV patients remain alive at follow-up (55% vs 11%; p = .003).
  • Quality of life outcomes favor DOV, with 78% “excellent” vs 27% in TAE (p = .018).
  • Multiple arterial supply sources (e.g., gastric, phrenic, intercostal arteries) complicate complete embolization and contribute to recurrence (Figure 6, page 17).
  • Restoration of hepatopetal portal flow is a key success indicator, particularly after DOV occlusion (page 16 discussion).

Simini Surgery Review Podcast

How critical is this paper for crushing the Boards?

🚨 Must-know. I’d bet on seeing this.

📚 Useful background, not must-know.

💤 Skip it. Doubt it’ll ever show up.

Thanks for the feedback!
We'll keep fine-tuning the articles vault.
Oops — didn’t go through.
Mind trying that again?

Weisse et al: Procedural descriptions and survival times for hepatic arteriovenous malformations (HAVM) in animals receiving primarily conservative treatment, arterial embolization, or dominant outflow vein occlusion
Veterinary Surgery 3, 2026

🔍 Key Findings

  • Surgical management significantly improves survival vs medical therapy, with MST ~1942d vs 567d (p = .028), supporting intervention over conservative care.
  • DOV occlusion achieves superior initial occlusion rates (95% vs 56% for TAE; p = .007), making it more reliable for immediate flow cessation.
  • TAE has significantly higher recurrence rates (53% vs 15% for DOV; p < .001), often requiring repeat procedures.
  • Residual HAVM flow is more common after TAE (44% vs 5%), reflecting difficulty targeting the nidus via arterial routes.
  • Overall survival time between TAE and DOV is not significantly different, but more DOV patients remain alive at follow-up (55% vs 11%; p = .003).
  • Quality of life outcomes favor DOV, with 78% “excellent” vs 27% in TAE (p = .018).
  • Multiple arterial supply sources (e.g., gastric, phrenic, intercostal arteries) complicate complete embolization and contribute to recurrence (Figure 6, page 17).
  • Restoration of hepatopetal portal flow is a key success indicator, particularly after DOV occlusion (page 16 discussion).

Simini Surgery Review Podcast

Know What Matters in the Literature - and Why

We distill peer-reviewed surgical studies into clinically relevant summaries and
exam-style questions, so you can make informed decisions with confidence.

Free Access. No Spam. Just Smarter Surgical Learning

Multiple Choice Questions on this study

In Weisse 2026 et al., on HAVM treatment outcomes, how did survival compare between surgical and medical management?

A. Medical management had longer survival
B. No difference between groups
C. Surgical management significantly improved survival
D. TAE alone was inferior to medical therapy
E. DOV had worse survival than medical therapy

Answer: Surgical management significantly improved survival

Explanation: Surgical treatment resulted in significantly longer MST compared to conservative therapy (p = .028).
In Weisse 2026 et al., on HAVM treatment outcomes, why does DOV occlusion often achieve better durability than TAE?

A. It removes affected liver lobes
B. It increases arterial inflow
C. It eliminates the low-pressure venous outflow driving the AVM
D. It prevents portal hypertension entirely
E. It blocks all hepatic arteries

Answer: It eliminates the low-pressure venous outflow driving the AVM

Explanation: DOV targets the venous outflow (“sump”), promoting thrombosis of the nidus and reducing recurrence compared to arterial embolization.
In Weisse 2026 et al., on HAVM treatment outcomes, what was a key limitation of transarterial embolization (TAE)?

A. Inability to access hepatic arteries
B. High perioperative mortality
C. Incomplete nidus occlusion and persistent flow
D. Excessive portal hypertension
E. High rate of portal vein thrombosis

Answer: Incomplete nidus occlusion and persistent flow

Explanation: TAE frequently resulted in residual flow (44%) due to difficulty targeting the nidus and complex arterial supply.
In Weisse 2026 et al., on HAVM treatment outcomes, which intervention resulted in the lowest recurrence rate?

A. Medical management alone
B. Transarterial embolization (TAE)
C. Dominant outflow vein (DOV) occlusion
D. Hepatic lobectomy
E. Combined TAE and lobectomy

Answer: Dominant outflow vein (DOV) occlusion

Explanation: DOV had significantly lower recurrence (15%) vs TAE (53%), making it the most durable technique.
In Weisse 2026 et al., on HAVM treatment outcomes, which finding best indicates successful treatment intraoperatively?

A. Reduction in ALT levels
B. Development of ascites
C. Restoration of hepatopetal portal flow
D. Decrease in heart murmur intensity
E. Normalization of hematocrit

Answer: Restoration of hepatopetal portal flow

Explanation: Return of hepatopetal portal flow indicates successful elimination of arteriovenous shunting and improved portal perfusion.

Access the full library of surgical summaries and exam-style questions.

Educational content developed independently and supported by Simini.

The maker of Simini Protect Lavage.

Something off with this article?
Tell us what needs fixing—drop your note below.
Thanks for flagging this!
We’ll review your note as soon as possible.
Oops! Something went wrong while submitting the form.
Anything to add to this article?
Know a finding or detail we missed? Share it below.
Thanks for the suggestion!
We’ll review it as soon as possible.
Oops! Something went wrong while submitting the form.